26 January 2022 in Journal of Cachexia, Sarcopenia and Muscle
Background: Duchenne muscular dystrophy (DMD) is caused by DMD mutations leading to dystrophin loss. Full‐length Dp427 is the primary dystrophin isoform expressed in muscle and is also expressed in the central nervous system (CNS). Two shorter isoforms, Dp140 and Dp71, are highly expressed in the CNS. While a role for Dp140 and Dp71 on DMD CNS comorbidities is well known, relationships between mutations expected to disrupt Dp140 and Dp71 and motor outcomes are not.Methods: Functional outcome data from 387 DMD boys aged 4–15 years were subdivided by DMD mutation expected effects on dystrophin isoform expression; Group 1 (Dp427 absent, Dp140/Dp71 present, n = 201); Group 2 (Dp427/Dp140 absent, Dp71 present, n = 152); and Group 3 (Dp427/Dp140/Dp71 absent, n = 34). Relationships between isoform group and North Star ambulatory assessment (NSAA) scores, 10 m walk/run velocities and rise time velocities were explored using regression analysis.Western blot analysis was used to study Dp427, Dp140 and Dp71 production in myogenic cells (control and DMD human), control skeletal muscle, DMD skeletal muscle from the three isoform groups and cerebral cortex from mice (wild‐type and DMD models). Grip strength and rotarod running test were studied in wild‐type mice and DMD mouse models. DMD mouse models were mdx (Dp427 absent, Dp140/Dp71 present), mdx52 (Dp427/Dp140 absent, Dp71 present) and DMD‐null (lacking all isoforms).Results: In DMD boys, mean NSAA scores at 5 years of age were 6.1 points lower in Group 3 than Group 1 (P < 0.01) and 4.9 points lower in Group 3 than Group 2 (P = 0.05). Mean peak NSAA scores were 4.0 points lower in Group 3 than Group 1 (P < 0.01) and 1.6 points lower in Group 2 than Group 1 (P = 0.04).Mean four‐limb grip strength was 1.5 g/g lower in mdx52 than mdx mice (P = 0.003) and 1.5 g/g lower in DMD‐null than mdx mice (P = 0.002).Dp71 was produced in myogenic cells (control and DMD human) and skeletal muscle from humans in Groups 1 and 2 and mdx mice, but not skeletal muscle from human controls, myogenic cells and skeletal muscle from humans in Group 3 or skeletal muscle from wild‐type, mdx52 or DMD‐null mice.Conclusions: Our results highlight the importance of considering expected effects of DMD mutations on dystrophin isoform production when considering patterns of DMD motor impairment and the implications for clinical practice and clinical trials. Our results suggest a complex relationship between dystrophin isoforms expressed in the brain and DMD motor function.
24 June 2025 in Annals of Clinical and Translational Neurology
Objective: In Duchenne muscular dystrophy (DMD), lack of the shorter dystrophin isoforms Dp140 and Dp71 is associated with increased central nervous system (CNS) involvement. We aimed to investigate how CNS involvement affects motor development in young DMD boys.Method: Three hundred and forty‐two DMD boys aged 3–6 years were subdivided according to DMD mutation expected effects on isoform expression: Group 1 (Dp427 absent, Dp140/Dp71 present, n = 170); Group 2 (Dp427/Dp140 absent, Dp71 present, n = 154) and Group 3 (Dp427/Dp140/Dp71 absent, n = 18). Mixed effects logistic regression was used to investigate relationships between isoform group and the odds of achieving higher North Star Ambulatory Assessment (NSAA) subitem scores for 15 subitems, adjusting for age at visit and glucocorticoid exposure.Results: The odds of achieving a full score of 2 were significantly lower for 11 NSAA subitems in Group 2 compared to Group 1, 5 NSAA subitems in Group 3 compared to Group 1, and 2 NSAA subitems in Group 3 compared to Group 2. The odds of achieving a score of 2 or 1 compared to 0 were significantly lower in Group 2 compared to Group 1 for the 2 NSAA subitems studied using this comparison.Interpretation: We found strong and significant associations between the odds of achieving higher NSAA subitem scores and expected patterns of dystrophin isoform involvement, with a cumulative effect of loss of isoforms. This suggests an important relationship between dystrophin isoforms in the brain and the ability to carry out gross motor milestones.
14 March 2025 in Developmental Medicine & Child Neurology
Aim: To investigate the associations between mutations expected to differentially affect Dp140 expression and long‐term trajectories of respiratory and upper‐limb motor outcomes in Duchenne muscular dystrophy (DMD).Method: In a retrospective analysis of population‐based longitudinal data from three real‐world and natural history data sources, individuals with DMD aged 5 years to 18 years were subdivided according to the predicted effects of the participants' DMD mutation on dystrophin isoform expression (group 1, Dp427 absent, Dp140/Dp71 present; group 2, Dp427/Dp140 absent, Dp71 present).Results: A total of 459 participants were studied, with upper‐limb outcomes assessed in 71 (27 in group 1 and 44 in group 2) and forced vital capacity percentage predicted (%pred) assessed in 434 (224 in group 1 and 210 in group 2). Mean grip strength %pred was on average 7.1 percentage points lower in group 2 than in group 1 (p = 0.03). Mean pinch strength %pred was on average 9.2 percentage points lower in group 2 than in group 1 (p = 0.04). Mean forced vital capacity %pred was on average 4.3 percentage points lower in group 2 than in group 1 (p = 0.01).Interpretation: In individuals with DMD, DMD mutations predicted to affect Dp140 expression were associated with more severe trajectories of respiratory and upper‐limb motor outcomes.